Title |
Phylodynamics of HIV-1 from a Phase III AIDS Vaccine Trial in Bangkok, Thailand
|
---|---|
Published in |
PLOS ONE, March 2011
|
DOI | 10.1371/journal.pone.0016902 |
Pubmed ID | |
Authors |
Marcos Pérez-Losada, David V. Jobes, Faruk Sinangil, Keith A. Crandall, Miguel Arenas, David Posada, Phillip W. Berman |
Abstract |
In 2003, a phase III placebo-controlled trial (VAX003) was completed in Bangkok, Thailand. Of the 2,546 individuals enrolled in the trial based on high risk for infection through injection drug use (IDU), we obtained clinical samples and HIV-1 sequence data (envelope glycoprotein gene gp120) from 215 individuals who became infected during the trial. Here, we used these data in combination with other publicly available gp120 sequences to perform a molecular surveillance and phylodynamic analysis of HIV-1 in Thailand. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
New Zealand | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 4% |
United Kingdom | 1 | 2% |
South Africa | 1 | 2% |
Unknown | 52 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 15 | 27% |
Researcher | 13 | 23% |
Other | 6 | 11% |
Student > Master | 4 | 7% |
Professor > Associate Professor | 3 | 5% |
Other | 8 | 14% |
Unknown | 7 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 41% |
Medicine and Dentistry | 10 | 18% |
Biochemistry, Genetics and Molecular Biology | 4 | 7% |
Economics, Econometrics and Finance | 3 | 5% |
Computer Science | 2 | 4% |
Other | 5 | 9% |
Unknown | 9 | 16% |